Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DANIEL LEBOVIC

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1740302850
CMS profile
169543
Location
GROSSE POINTE WOODS, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$42,671.04

30 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $16,336.59 9
Genentech USA, Inc. $14,495.74 9
Amgen Inc. $7,183.95 5
ABBVIE INC. $4,500.00 2
Adaptive Biotechnologies Corporation $71.28 1
GlaxoSmithKline, LLC. $35.54 2
E.R. Squibb & Sons, L.L.C. $33.65 1
Astellas Pharma US Inc $14.29 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

30 matching records · $42,671.04 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 30 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–30 of 30.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $2,250.0012/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026997739587 CMS
Amgen Inc. $58.9512/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019881547 CMS
Amgen Inc. $3,000.0012/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019881549 CMS
Amgen Inc. $500.0012/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019881553 CMS
Genentech USA, Inc. $4,040.0011/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335939 CMS
Genentech USA, Inc. $138.7511/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335945 CMS
Genentech USA, Inc. $16.2911/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335951 CMS
Genentech USA, Inc. $322.0011/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335960 CMS
GENZYME CORPORATION $79.5211/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102681 CMS
GENZYME CORPORATION $4,392.0011/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102685 CMS
GENZYME CORPORATION $188.6411/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102689 CMS
Genentech USA, Inc. $1,520.0011/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335975 CMS
GENZYME CORPORATION $1,238.0008/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102657 CMS
Genentech USA, Inc. $276.0008/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335929 CMS
Genentech USA, Inc. $4,040.0008/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335933 CMS
Genentech USA, Inc. $102.7007/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335963 CMS
Genentech USA, Inc. $4,040.0007/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335971 CMS
GlaxoSmithKline, LLC. $17.4507/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002027243 CMS
ABBVIE INC. $2,250.0007/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026997739585 CMS
Amgen Inc. $3,000.0006/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019881539 CMS
GENZYME CORPORATION $3,660.0006/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102642 CMS
GENZYME CORPORATION $115.9406/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102645 CMS
GENZYME CORPORATION $2,928.0005/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102607 CMS
Amgen Inc. $625.0004/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261019881543 CMS
GENZYME CORPORATION $74.4903/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102575 CMS
GENZYME CORPORATION $3,660.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050102579 CMS
Astellas Pharma US Inc $14.2903/07/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261033949943 CMS
Adaptive Biotechnologies Corporation $71.2802/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261022975307 CMS
GlaxoSmithKline, LLC. $18.0902/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002005257 CMS
E.R. Squibb & Sons, L.L.C. $33.6501/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015305361 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $98,314.47 111
PY2020 $47,290.71 31
PY2021 $62,087.78 32
PY2022 $55,911.76 36
PY2023 $42,671.04 30
PY2024 $23,956.52 20
PY2025 $21,430.68 20

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
DANIEL LEBOVIC, NPI 1740302850. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1740302850.
APA 7
IndustryPayments. (2026). DANIEL LEBOVIC, NPI 1740302850 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1740302850
Bluebook
DANIEL LEBOVIC, NPI 1740302850, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1740302850.

Source: Centers for Medicare & Medicaid Services, Open Payments.